Creating mega-ventures with a market capitalization of ¥100 billion or more
First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2025.
2 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「If, in any fiscal year from the fiscal year ending December 2025 through the fiscal year ending December 2032, net sales stated in the audited consolidated statements of income included in the company’s Securities Report, or in the statement of income if consolidated statements of income are not prepared, are at least ¥13 billion and ordinary profit is at least ¥1 billion」
The company continues to disclose the medium- to long-term targets of net sales of ¥13 billion, ordinary profit of ¥1 billion, a market capitalization of ¥100 billion or a listing on the Prime Market as exercise conditions for the Eighth and Ninth Series Stock Acquisition Rights. - FY2025-H1RestatedAnnual report
「If, in any fiscal year from the fiscal year ending December 2025 through the fiscal year ending December 2032, net sales stated in the audited consolidated statements of income included in the company’s Securities Report, or in the statement of income if consolidated statements of income are not prepared, are at least ¥13 billion and ordinary profit is at least ¥1 billion」
The company reiterated the target conditions for exercising the Eighth and Ninth Series Stock Acquisition Rights: net sales of ¥13 billion and ordinary profit of ¥1 billion from the fiscal year ending December 2025 through the fiscal year ending December 2032, a market capitalization of ¥100 billion, or a listing on the Prime Market. - FY2023First statedAnnual report
「The company will introduce an equity incentive package comparable to those used by US companies, thereby securing management executives’ financial and career commitments to long-term growth and creating a “mega-venture” with a market capitalization of at least ¥100 billion.」
For the Eighth and Ninth Series Stock Acquisition Rights, the company presented new growth targets as exercise conditions: net sales of at least ¥13 billion and ordinary profit of at least ¥1 billion in any fiscal year from the fiscal year ending December 2025 through the fiscal year ending December 2032, a market capitalization of at least ¥100 billion for 5 consecutive business days, or a listing on the TSE Prime Market.